Characterization of Dyslipidemia in Adolescent Obesity

The primary objective of this pilot study is to characterize the profile of lipoprotein, inflammatory, and metabolic markers of cardiovascular disease in obese adolescents as compared to normal-weight age-matched controls.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

13 year–19 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The Center for Nutrition and Preventive Medicine

Charlotte, North Carolina, 28277, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 13-19
BMI ≥25 (obese) or <25 (normal weight)

Exclusion criteria

Prior diagnosis of any eating disorder (e.g. anorexia or bulimia)
Prior diagnosis of any congenital lipid disorder (e.g. familial hypercholesterolemia)
Current use (or within past 6 months) of any lipid altering medications

Treatment and study plan

Primary outcomes

Comparison of biomarker profiles

Time frame: Baseline

To characterize and compare lipoprotein, inflammation and metabolic markers in obese and normal weight adolescents.

Sponsors and collaborators

Lead sponsor

Health Diagnostic Laboratory, Inc.

Industry

Registry information

Important dates

Study start: 2011
Primary completion: 2014
Study completion: 2014
First posted: Nov 20, 2013
Registry last updated: Feb 13, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed